The Relevance of Reperfusion Stroke Therapy for miR-9-3p and miR-9-5p Expression in Acute Stroke-A Preliminary Study

• Published in: International journal of molecular sciences Vol. 25; no. 5; p. 2766
• Main Authors: Gendosz de Carrillo, Daria, Kocikowska, Olga, Rak, Małgorzata, Krzan, Aleksandra, Student, Sebastian, Jędrzejowska-Szypułka, Halina, Pawletko, Katarzyna, Lasek-Bal, Anetta
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 27.02.2024; MDPI
• Subjects: Analysis; Biomarkers; Blood clot; Genes; hsa-miR-9-3p; hsa-miR-9-5p; Humans; Hypoxia; Ischemia; MicroRNA; MicroRNAs; MicroRNAs - genetics; miRNA; Morphogenesis; NGS; Patients; Reperfusion; reperfusion treatment; Signal Transduction - genetics; Stroke; Thrombosis; Poland; enrichment analysis; GO; KEGG; miRNA; NGS; reperfusion treatment; hsa-miR-9-3p; stroke; hsa-miR-9-5p
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms25052766

Reperfusion stroke therapy is a modern treatment that involves thrombolysis and the mechanical removal of thrombus from the extracranial and/or cerebral arteries, thereby increasing penumbra reperfusion. After reperfusion therapy, 46% of patients are able to live independently 3 months after stroke onset. MicroRNAs (miRNAs) are essential regulators in the development of cerebral ischemia/reperfusion injury and the efficacy of the applied treatment. The first aim of this study was to examine the change in serum miRNA levels via next-generation sequencing (NGS) 10 days after the onset of acute stroke and reperfusion treatment. Next, the predictive values of the bioinformatics analysis of miRNA gene targets for the assessment of brain ischemic response to reperfusion treatment were explored. Human serum samples were collected from patients on days 1 and 10 after stroke onset and reperfusion treatment. The samples were subjected to NGS and then validated using qRT-PCR. Differentially expressed miRNAs (DEmiRNAs) were used for enrichment analysis. Hsa-miR-9-3p and hsa-miR-9-5p expression were downregulated on day 10 compared to reperfusion treatment on day 1 after stroke. The functional analysis of miRNA target genes revealed a strong association between the identified miRNA and stroke-related biological processes related to neuroregeneration signaling pathways. Hsa-miR-9-3p and hsa-miR-9-5p are potential candidates for the further exploration of reperfusion treatment efficacy in stroke patients.